Stuart A. Arbuckle - 10 Feb 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2025
Net transactions value
-$1,506,896
Form type
4
Filing time
12 Feb 2025, 16:26:45 UTC
Previous filing
06 Feb 2025
Next filing
14 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $1,506,896 -3,220 -4.4% $467.98 69,543 10 Feb 2025 Direct
holding VRTX Common Stock 140 10 Feb 2025 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.